東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Statistical Methodologies for Trial ...

Ye, Fangshu.

FindBook

Google Book

Amazon

博客來

Statistical Methodologies for Trial Design With Network Meta-Analysis.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Statistical Methodologies for Trial Design With Network Meta-Analysis./
作者:	Ye, Fangshu.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2023,
面頁冊數:	95 p.
附註:	Source: Dissertations Abstracts International, Volume: 85-03, Section: B.
Contained By:	Dissertations Abstracts International85-03B.
標題:	Statistics. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30424551
ISBN:	9798380155182

Statistical Methodologies for Trial Design With Network Meta-Analysis.
Ye, Fangshu.

Statistical Methodologies for Trial Design With Network Meta-Analysis. - Ann Arbor : ProQuest Dissertations & Theses, 2023 - 95 p.

Source: Dissertations Abstracts International, Volume: 85-03, Section: B.

Thesis (Ph.D.)--Iowa State University, 2023.

This item must not be sold to any third party vendors.

Network meta-analysis (NMA) is a tool increasingly used in human and animal health to understand the comparative effect of interventions. One of the unique features of network meta-analysis is the ability to generate estimates of comparative efficacy when no direct clinical trial exists, which introduce the possibility to leverage evidence from the existing network of trial to inform the design of a new trial. Although there are methods proposed based on NMA to plan new trials, methodology for specific applications and the potential misuse of NMA in designing new trials are lacking. Our research focused on designing a new trial for two scenarios of comparison of interest: 1) two treatments in the existing network; 2) one treatment is in the existing network and the other one is not in the existing network. In Chapter 2, we propose an NMA-based method that can increase the power for a fixed total sample size or minimize the required total sample size to reach a pre-specified power when designing a new two-arm trial. In addition, we implement our proposed method into the R package OssaNMA and launch an R Shiny app for the convenience of the application. In Chapter 3, we investigate the potential inflation of type I error risk when a new trial is conducted only when, based on a p-value of the comparison in the existing network, a "promising" difference between two treatments is noticed. In Chapter 4, we consider how to design a new trial when the comparison of interest is between a treatment in the existing network and a treatment not in the existing network. All the methods are proposed from formula derivation and validated by simulation studies. Application of our work can provide insightful guidance for researchers to design a resource-saving new trial without misuse of NMA.

ISBN: 9798380155182Subjects--Topical Terms:

517247
Statistics.
Subjects--Index Terms:

Clinical trial design

Statistical Methodologies for Trial Design With Network Meta-Analysis.
LDR:03059nmm a2200397 4500 001 2393919
005 20240414211922.5
006 m o d
007 cr#unu||||||||
008 251215s2023 ||||||||||||||||| ||eng d
020 $a 9798380155182
035 $a (MiAaPQ)AAI30424551
035 $a AAI30424551
040 $a MiAaPQ $c MiAaPQ
100 1 $a Ye, Fangshu. $0 (orcid)0000-0001-6994-1210 $3 3763399
245 1 0 $a Statistical Methodologies for Trial Design With Network Meta-Analysis.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2023
300 $a 95 p.
500 $a Source: Dissertations Abstracts International, Volume: 85-03, Section: B.
500 $a Advisor: Wang, Chong;O'Connor, Annette M.
502 $a Thesis (Ph.D.)--Iowa State University, 2023.
506 $a This item must not be sold to any third party vendors.
520 $a Network meta-analysis (NMA) is a tool increasingly used in human and animal health to understand the comparative effect of interventions. One of the unique features of network meta-analysis is the ability to generate estimates of comparative efficacy when no direct clinical trial exists, which introduce the possibility to leverage evidence from the existing network of trial to inform the design of a new trial. Although there are methods proposed based on NMA to plan new trials, methodology for specific applications and the potential misuse of NMA in designing new trials are lacking. Our research focused on designing a new trial for two scenarios of comparison of interest: 1) two treatments in the existing network; 2) one treatment is in the existing network and the other one is not in the existing network. In Chapter 2, we propose an NMA-based method that can increase the power for a fixed total sample size or minimize the required total sample size to reach a pre-specified power when designing a new two-arm trial. In addition, we implement our proposed method into the R package OssaNMA and launch an R Shiny app for the convenience of the application. In Chapter 3, we investigate the potential inflation of type I error risk when a new trial is conducted only when, based on a p-value of the comparison in the existing network, a "promising" difference between two treatments is noticed. In Chapter 4, we consider how to design a new trial when the comparison of interest is between a treatment in the existing network and a treatment not in the existing network. All the methods are proposed from formula derivation and validated by simulation studies. Application of our work can provide insightful guidance for researchers to design a resource-saving new trial without misuse of NMA.
590 $a School code: 0097.
650 4 $a Statistics. $3 517247
650 4 $a Biostatistics. $3 1002712
653 $a Clinical trial design
653 $a Evidence synthesis
653 $a Network meta-analysis
653 $a Sequential analysis
653 $a Statistical methodologies
690 $a 0463
690 $a 0778
690 $a 0308
710 2 $a Iowa State University. $b Statistics. $3 1020860
773 0 $t Dissertations Abstracts International $g 85-03B.
790 $a 0097
791 $a Ph.D.
792 $a 2023
793 $a English
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30424551